BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18006943)

  • 1. Sex- and kindred-specific familial risk of non-Hodgkin's lymphoma.
    Czene K; Adami HO; Chang ET
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2496-9. PubMed ID: 18006943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study.
    Paltiel O; Schmit T; Adler B; Rachmilevitz EA; Polliack A; Cohen A; Haim N; Shachar MB; Epelbaum R; Barchana M; Cohen R; Ben Yehuda D
    Cancer; 2000 May; 88(10):2357-66. PubMed ID: 10820359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family history of hematopoietic and non-hematopoietic malignancies and risk of non-Hodgkin lymphoma.
    Zhang Y; Wang R; Holford TR; Leaderer B; Zahm SH; Boyle P; Zhu Y; Qin Q; Zheng T
    Cancer Causes Control; 2007 May; 18(4):351-9. PubMed ID: 17206533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
    Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
    Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma.
    Chiu BC; Weisenburger DD; Zahm SH; Cantor KP; Gapstur SM; Holmes F; Burmeister LF; Blair A
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):525-31. PubMed ID: 15066915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.
    Broccia G; Cocco P; Casula P;
    Haematologica; 2001 Jan; 86(1):58-63. PubMed ID: 11146572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial aggregation of Hodgkin lymphoma and related tumors.
    Goldin LR; Pfeiffer RM; Gridley G; Gail MH; Li X; Mellemkjaer L; Olsen JH; Hemminki K; Linet MS
    Cancer; 2004 May; 100(9):1902-8. PubMed ID: 15112271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden.
    Czene K; Hemminki K
    J Urol; 2003 Apr; 169(4):1271-5. PubMed ID: 12629341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2 million children from Norway and Sweden.
    Bjørge T; Cnattingius S; Lie RT; Tretli S; Engeland A
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):500-6. PubMed ID: 18296646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
    Hemminki K; Lenner P; Sundquist J; Bermejo JL
    J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family history of hemolymphopoietic and other cancers and risk of non-Hodgkin's lymphoma.
    Negri E; Talamini R; Montella M; Dal Maso L; Crispo A; Spina M; La Vecchia C; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):245-50. PubMed ID: 16492911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial bladder cancer in the National Swedish Family Cancer Database.
    Plna K; Hemminki K
    J Urol; 2001 Dec; 166(6):2129-33. PubMed ID: 11696721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.
    Duberg AS; Nordström M; Törner A; Reichard O; Strauss R; Janzon R; Bäck E; Ekdahl K
    Hepatology; 2005 Mar; 41(3):652-9. PubMed ID: 15723449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma.
    Linet MS; Pottern LM
    Cancer Res; 1992 Oct; 52(19 Suppl):5468s-5473s. PubMed ID: 1394155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood social environment and risk of non-Hodgkin lymphoma in adults.
    Smedby KE; Hjalgrim H; Chang ET; Rostgaard K; Glimelius B; Adami HO; Melbye M
    Cancer Res; 2007 Nov; 67(22):11074-82. PubMed ID: 18006854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial and second gastric carcinomas: a nationwide epidemiologic study from Sweden.
    Hemminki K; Jiang Y
    Cancer; 2002 Feb; 94(4):1157-65. PubMed ID: 11920487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.